Early Prediction of Treatment Response of Neuroendocrine Hepatic Metastases after Peptide Receptor Radionuclide Therapy with Y-DOTATOC Using Diffusion Weighted and Dynamic Contrast-Enhanced MRI
Weikert T, Maas O, Haas T, Klarhöfer M, Bremerich J, Forrer F, Sauter A, Sommer G. Early Prediction of Treatment Response of Neuroendocrine Hepatic Metastases after Peptide Receptor Radionuclide Therapy with Y-DOTATOC Using Diffusion Weighted and Dynamic Contrast-Enhanced MRI. Contrast Media Mol Imaging 2019; 2019:1517208.
11.11.2019
Early Prediction of Treatment Response of Neuroendocrine Hepatic Metastases after Peptide Receptor Radionuclide Therapy with Y-DOTATOC Using Diffusion Weighted and Dynamic Contrast-Enhanced MRI
11.11.2019
Contrast Media Mol Imaging 2019; 2019:1517208
Weikert Thomas, Maas Ole, Haas Tanja, Klarhöfer Markus, Bremerich Jens, Forrer Flavio, Sauter Alexander Walter, Sommer Gregor
Weiter
